The Pharma Data

DECEMBER 5, 2020

Founded and led for 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories.

Antibody 40

Antibody Production Trials Medicine 40

The Pharma Data

JANUARY 24, 2021

Dr. Van Slyke is a biotechnology entrepreneur, scientist, and serial inventor. Sairiyo is advancing the clinical development of its lead drug candidate, Cepharanthine, a repurposed and reformulated naturally derived compound for the potential treatment of cancer, neurological, inflammatory and infectious diseases.

Drugs 52

Drugs Containment Development Clinical Development 52

The Pharma Data

JANUARY 12, 2021

Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to eight FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories.

Antibody 52

Antibody Production Manufacturing Clinical Trials 52

The Pharma Data

NOVEMBER 20, 2020

The EUA is temporary and does not take the place of a formal biologics license application (BLA) submission review and approval process. The FDA grants Emergency Use Authorization to medicines that may help diagnose, treat or prevent a life-threatening disease when adequate and approved alternatives are not available.

Antibody 52

Antibody Production Clinical Trials Clinical Trials 52

Pharma Marketing Network

JUNE 10, 2020

Most recently, telemedicine and specialty pharmacy connected together to create a product that a consumer can get directly. You go online, you talk to a doctor via telemedicine, and a specialty pharmacy then delivers it for you. And that reduces a time of drug discovery from 10 years to five years. So, this boxification of things.

Marketing 52

Marketing Clinical Trials Clinical Trials Nurses 52

The Pharma Data

NOVEMBER 5, 2020

The FDA accepted for priority review, with a target action date of February 28, 2021 , the supplemental Biologics License Application (sBLA) for Libtayo ® (cemiplimab) as monotherapy to treat patients with first-line locally advanced or metastatic non-small cell lung cancer (NSCLC) with ?50% Oncology Program. 50% PD-L1 expression.

Sales 40

Sales Production Manufacturing Antibody 40

The Pharma Data

NOVEMBER 20, 2020

Eiger licensed exclusive worldwide rights to lonafarnib from Merck, known as MSD outside of the United States and Canada. Merck will not receive any milestone payments for the development of lonafarnib for the treatment of Progeria, and has waived royalty obligations from Eiger for a specified quantity of lonafarnib.

FDA Approval 52

FDA Approval Genetics Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 21, 2020

The EUA is temporary and does not take the place of a formal biologics license application (BLA) submission review and approval process. The FDA grants Emergency Use Authorization to medicines that may help diagnose, treat or prevent a life-threatening disease when adequate and approved alternatives are not available.

Antibody 40

Antibody Production Clinical Trials Clinical Trials 40

Pharma Marketing Network

JUNE 10, 2020

Most recently, telemedicine and specialty pharmacy connected together to create a product that a consumer can get directly. You go online, you talk to a doctor via telemedicine, and a specialty pharmacy then delivers it for you. And that reduces a time of drug discovery from 10 years to five years. So, this boxification of things.

Marketing 40

Marketing Clinical Trials Clinical Trials Nurses 40

The Pharma Data

DECEMBER 29, 2020

The EUA is temporary and does not take the place of a formal biologics license application (BLA) submission review and approval process and the use of the antibody cocktail remains investigational. Food and Drug Administration (FDA) in high-risk patients who have confirmed COVID-19 but are not currently hospitalized.

Antibody 52

Antibody Trials Production Clinical Trials 52

The Pharma Data

OCTOBER 14, 2020

“Decades of investment in our VelociSuite® rapid response technologies, the dedication of world-class scientists, and the courageous contributions of healthcare providers and patients, together with remarkable cooperation between leading international health organizations and governments, have led to this important moment.

FDA Approval 52

FDA Approval Antibody Production Trials 52

pharmaphorum

SEPTEMBER 1, 2020

The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. Originating as a pharmacy founded in Darmstadt in 1668, it was in 1827 that Heinrich Emanuel Merck began the transition towards an industrial and scientific concern, by manufacturing and selling alkaloids.

Medicine 145

Medicine Insulin Drugs Pharmacy 145

The Pharma Data

MAY 13, 2021

Top scientists question the need for COVID-19 booster shots ( Reuters ). ‘More Amazon and less pharmacy’: one exec on the company’s strategy for prescription drugs ( STAT ). Biogen licenses a stroke drug from Japanese drugmaker TMS ( BioPharmaDive ). In Focus: International.

FDA Approval 52

FDA Approval Vaccination Vaccine Drugs 52